MNTA: @2008 several of us postulated that Enbrel and Remicade were possible candidates for the collaboration with Sandoz (which were terminated). It makes sense, therefore, that MNTA may still be developing these solo if they ever were with Sandoz (or, even if they weren't previously).
"If we don't succeed, we run the risk of failure." -Dan Quayle
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.